Description
Neuroprotective & Tissue-Protection Peptide Research
ARA-290 is a synthetic peptide derived from a specific region of erythropoietin but designed to retain tissue-protective signaling without stimulating red-blood-cell production.
Researchers have investigated ARA-290 in relation to the body’s innate repair receptor, with particular interest in neurological protection, neuropathic symptoms, metabolic biology, and tissue repair.
A Phase 2 study investigated ARA-290 in people with type 2 diabetes and painful neuropathy, reporting improvements in several exploratory metabolic and neuropathy-related measures. Larger studies are needed to establish its clinical significance.
Research Focus: Neuroprotection • Tissue repair • Neuropathy research • Metabolic signaling
Research Status: Investigational peptide.
